Yi Cao1, Fei Wang2, Qianpeng Cheng1, Xiumin Jiao1, Xiaofeng Lv1. 1. Department of Endocrinology, The General Hospital of Beijing Military Area Command Beijing 100700, China. 2. Department of Orthopedic Surgery, The General Hospital of Beijing Military Area Command Beijing 100700, China.
Abstract
OBJECTIVE: This study determined the relationship between fasting glucose levels of cerebral infarction patients and the hospitalization time and relapse and mortality rates. METHODS: A retrospective study was conducted between February 1996 and December 2006 involving 974 inpatients with cerebral infarctions. Fasting blood glucose and lipid levels and blood pressure were measured the morning after hospitalization. The length of hospital stay, and data obtained from telephone follow-up interviews regarding relapse and complications were recorded. The data were analyzed using multiple linear regressions, logistic regression, the chi-square test, and the Kruskal-Wallis analysis of variance of ranks test. RESULTS: Our data show that the duration of hospitalization and relapse and mortality rates of patients with cerebral infarctions correlate with the admission fasting blood glucose levels. Cerebral infarction patients with fasting blood glucose levels > 11.1 mmol/L and LDL levels > 3.5 mmol/L have higher mortality rates (50.00%). Patients with fasting blood glucose levels > 11.1 mmol/L combined with a diastolic pressure < 80 mmHg or > 100 mmHg also have high mortality rates (33.33% and 30.00%, respectively). CONCLUSIONS: Fasting glucose levels of inpatients with cerebral infarctions are closely related to the duration of hospitalization and relapse and mortality rates. Higher fasting blood glucose levels exacerbate damage to cerebral blood vessels caused by alterations in blood lipid levels and blood pressure. Therefore, blood glucose levels should be monitored during the early stage of cerebral infarction and intervention should be provided promptly to decrease the length of hospital stay and the risk of relapse and mortality.
OBJECTIVE: This study determined the relationship between fasting glucose levels of cerebral infarctionpatients and the hospitalization time and relapse and mortality rates. METHODS: A retrospective study was conducted between February 1996 and December 2006 involving 974 inpatients with cerebral infarctions. Fasting blood glucose and lipid levels and blood pressure were measured the morning after hospitalization. The length of hospital stay, and data obtained from telephone follow-up interviews regarding relapse and complications were recorded. The data were analyzed using multiple linear regressions, logistic regression, the chi-square test, and the Kruskal-Wallis analysis of variance of ranks test. RESULTS: Our data show that the duration of hospitalization and relapse and mortality rates of patients with cerebral infarctions correlate with the admission fasting blood glucose levels. Cerebral infarctionpatients with fasting blood glucose levels > 11.1 mmol/L and LDL levels > 3.5 mmol/L have higher mortality rates (50.00%). Patients with fasting blood glucose levels > 11.1 mmol/L combined with a diastolic pressure < 80 mmHg or > 100 mmHg also have high mortality rates (33.33% and 30.00%, respectively). CONCLUSIONS: Fasting glucose levels of inpatients with cerebral infarctions are closely related to the duration of hospitalization and relapse and mortality rates. Higher fasting blood glucose levels exacerbate damage to cerebral blood vessels caused by alterations in blood lipid levels and blood pressure. Therefore, blood glucose levels should be monitored during the early stage of cerebral infarction and intervention should be provided promptly to decrease the length of hospital stay and the risk of relapse and mortality.
Authors: Karl Matz; Katharina Keresztes; Claudia Tatschl; Monika Nowotny; Alexandra Dachenhausen; Alexandra Dachenhausenm; Michael Brainin; Jaakko Tuomilehto Journal: Diabetes Care Date: 2006-04 Impact factor: 19.112
Authors: Blanca Fuentes; José Castillo; Belén San José; Rogelio Leira; Joaquín Serena; José Vivancos; Antonio Dávalos; Antonio Gil Nuñez; José Egido; Exuperio Díez-Tejedor Journal: Stroke Date: 2008-12-18 Impact factor: 7.914
Authors: Tracey A Baird; Mark W Parsons; Thanh Phan; Thanh Phanh; Ken S Butcher; Patricia M Desmond; Brian M Tress; Peter G Colman; Brian R Chambers; Stephen M Davis Journal: Stroke Date: 2003-07-31 Impact factor: 7.914
Authors: Marjukka Hyvärinen; Qing Qiao; Jaakko Tuomilehto; Tiina Laatikainen; Robert J Heine; Coen D A Stehouwer; K George M M Alberti; Kalevi Pyörälä; Björn Zethelius; Birgitta Stegmayr Journal: Diabetes Care Date: 2008-11-18 Impact factor: 17.152
Authors: Xin Guo; Li Shen; Jing Dou; Yaogai Lv; Anning Zhang; Fanchao Shi; Zhiqiang Xue; Yaqin Yu; Lina Jin; Yan Yao Journal: Int J Environ Res Public Health Date: 2017-11-10 Impact factor: 3.390